CClinicalTrials.gg
RecruitingNCT06641297Updated Feb 20, 2026

White Matter Plasticity in Schizophrenia

An interventional study of Music video game in Schizophrenia Disorders, sponsored by University of Maryland, Baltimore. Recruiting at 2 sites in United States. Open to participants aged 15 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-02-20.

Sponsored by University of Maryland, Baltimore · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
15 Years to 45 Years
Sex
All
01

Study summary

Schizophrenia spectrum disorders are associated with impairment in the microstructure of white matter, the key brain tissue responsible for fast communication between different brain regions necessary for any complex task. This white matter impairment is linked to problems with cognition in schizophrenia, especially slower processing speed. This project aims to study the potential for correcting white matter deficits in schizophrenia by examining mechanisms underlying white matter structure changes in response to training on playing a mock musical instrument.

02

Conditions studied

  • Schizophrenia Disorders

Browse trials for

Keywords

  • music
  • training
  • plasticity
03

In context

Schizophrenia

3,470 studies on the registry are indexed under Schizophrenia; 471 are open to participants now.

This study's planned enrollment of 36 is below the median of 70 across 2,871 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

University of Maryland, Baltimore is the lead sponsor of 687 studies on the registry; 130 are open to participants now.

Of its 90 completed or terminated interventional studies of FDA-regulated products, 63 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, or psychosis NOS
  • age 15-45
  • able to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • contraindications to MRI (metal implants, claustrophobia)
  • medical condition that limits use of hands (ie, arthritis)
  • Active or recent (within 6 months) substance use disorder other than nicotine
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Active comparator
    Active training

    Training sessions involving playing the video game 'Guitar Hero'

    Behavioral: Music video game

  • Placebo comparator
    Observation training

    Behavioral: Music video game

Interventions

  • BehavioralMusic video game

    The video game \'Guitar Hero\' will be used as the platform for training for participants to acquire a new \'skill\'

06

What researchers measure

Primary outcomes

  1. White matter microstructure

    fractional anisotropy of white matter tracts as assessed with diffusion tensor imaging

    Time frame: 3 weeks

Secondary outcomes

  1. Brain level of N-acetylaspartate

    NAA levels in motor cortex of brain as measured with magnetic resonance spectroscopy

    Time frame: 3 weeks

07

Study locations

1 of 2 sites recruiting
  • Maryland Psychiatric Research Center
    Catonsville, Maryland 21228, United States
    Recruiting
  • University of Maryland Baltimore - Maryland Psychiatric Research Center
    Catonsville, Maryland 21228, United States
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06641297
Lead sponsor
University of Maryland, Baltimore
Responsible party
Sponsor
First posted
Oct 15, 2024
Start date
Jan 2, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Feb 20, 2026

Study contacts

Joshua J Chiappelli, MD
Contact
jchiappe@som.umaryland.edu
4104026827

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion